SP3
Transcription factor Sp3
Also known as: SP3_HUMAN, SPR-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02447
- Gene
- SP3
- Ensembl
- ENSG00000172845
- Chromosome
- 2
- Canonical length
- 781 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene belongs to a family of Sp1 related genes that encode transcription factors that regulate transcription by binding to consensus GC- and GT-box regulatory elements in target genes. This protein contains a zinc finger DNA-binding domain and several transactivation domains, and has been reported to function as a bifunctional transcription factor that either stimulates or represses the transcription of numerous genes. Transcript variants encoding different isoforms have been described for this gene, and one has been reported to initiate translation from a non-AUG (AUA) start codon. Additional isoforms, resulting from the use of alternate downstream translation initiation sites, have also been noted. A related pseudogene has been identified on chromosome 13. [provided by RefSeq, Feb 2010]
Canonical amino-acid sequenceUniProt
781 residues, UniProt reviewed canonical sequence.
>Q02447|SP3
1 MTAPEKPVKQ EEMAALDVDS GGGGGGGGGH GEYLQQQQQH GNGAVAAAAA AQDTQPSPLA
61 LLAATCSKIG PPSPGDDEEE AAAAAGAPAA AGATGDLASA QLGGAPNRWE VLSATPTTIK
121 DEAGNLVQIP SAATSSGQYV LPLQNLQNQQ IFSVAPGSDS SNGTVSSVQY QVIPQIQSAD
181 GQQVQIGFTG SSDNGGINQE SSQIQIIPGS NQTLLASGTP SANIQNLIPQ TGQVQVQGVA
241 IGGSSFPGQT QVVANVPLGL PGNITFVPIN SVDLDSLGLS GSSQTMTAGI NADGHLINTG
301 QAMDSSDNSE RTGERVSPDI NETNTDTDLF VPTSSSSQLP VTIDSTGILQ QNTNSLTTSS
361 GQVHSSDLQG NYIQSPVSEE TQAQNIQVST AQPVVQHLQL QESQQPTSQA QIVQGITPQT
421 IHGVQASGQN ISQQALQNLQ LQLNPGTFLI QAQTVTPSGQ VTWQTFQVQG VQNLQNLQIQ
481 NTAAQQITLT PVQTLTLGQV AAGGAFTSTP VSLSTGQLPN LQTVTVNSID SAGIQLHPGE
541 NADSPADIRI KEEEPDPEEW QLSGDSTLNT NDLTHLRVQV VDEEGDQQHQ EGKRLRRVAC
601 TCPNCKEGGG RGTNLGKKKQ HICHIPGCGK VYGKTSHLRA HLRWHSGERP FVCNWMYCGK
661 RFTRSDELQR HRRTHTGEKK FVCPECSKRF MRSDHLAKHI KTHQNKKGIH SSSTVLASVE
721 AARDDTLITA GGTTLILANI QQGSVSGIGT VNTSATSNQD ILTNTEIPLQ LVTVSGNETM
781 ELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 63 nTPM
Expression across tissuesHPA
Tissue
- thymus: 63 nTPM
- tonsil: 50 nTPM
- bone marrow: 50 nTPM
- cervix: 48 nTPM
- placenta: 46 nTPM
- thyroid gland: 45 nTPM
Single-cell type
- neutrophils: 920 nCPM
- neutrophil progenitors: 450 nCPM
- monocytes: 289 nCPM
- innate lymphoid cells: 176 nCPM
- medullary thymic epithelial cells: 173 nCPM
- monocyte progenitors: 172 nCPM
Immune cell
- neutrophil: 27 nTPM
- NK-cell: 22 nTPM
- T-reg: 14 nTPM
- naive CD4 T-cell: 14 nTPM
- eosinophil: 13 nTPM
- MAIT T-cell: 13 nTPM
Brain region
- cerebellum: 38 nTPM
- white matter: 31 nTPM
- hypothalamus: 30 nTPM
- medulla oblongata: 29 nTPM
- midbrain: 29 nTPM
- spinal cord: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.15
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.63
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell differentiation
- definitive hemopoiesis
- embryonic camera-type eye morphogenesis
- embryonic placenta development
- embryonic process involved in female pregnancy
- embryonic skeletal system development
- enucleate erythrocyte differentiation
- granulocyte differentiation
- liver development
- lung development
- megakaryocyte differentiation
- monocyte differentiation
- myeloid progenitor cell differentiation
- natural killer cell differentiation
- negative regulation of DNA-templated transcription
- ossification
- positive regulation of DNA-templated transcription
- positive regulation of transcription by RNA polymerase II
- regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- T cell differentiation
- trophectodermal cell differentiation
Molecular functions
- chromatin binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SP3 as an antibody target. Whether an autoantibody or antibody against SP3 could matter depends on whether native SP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...